CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
Go back to CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec| (NASDAQ: CGON) | Delayed: 71.05 -2.68 (3.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.73 | 52 Week High | $ | |||
| Open | $75.07 | 52 Week Low | $ | |||
| Day High | $77.00 | P/E | N/A | |||
| Day Low | $70.54 | EPS | $ | |||
| Volume | 1,405,178 | |||||

